Literature DB >> 8656244

Simultaneous retroperitoneal, thoracic, and cervical resection of postchemotherapy residual masses in patients with metastatic nonseminomatous germ cell tumors of the testis.

P C Brenner1, H W Herr, M J Morse, J Sheinfeld, A Aprikian, G J Bosl, R J Motzer, D F Bajorin, S Schantz, W R Fair, M Burt.   

Abstract

PURPOSE: We report our experience with simultaneous resection of residual masses above and below the diaphragm in patients with metastatic nomseminomatous germ cell tumor (NSGCT) of the testis.
MATERIALS AND METHODS: Twenty-four patients underwent simultaneous resection of residual postchemotherapy masses in the retroperitoneum and chest, including three who also had radical neck dissection. All had been heavily pretreated with chemotherapy and five had undergone previous retroperitoneal lymph node dissections (RPLNDs).
RESULTS: The combined procedure was performed with no mortality and low morbidity. The median length of the procedure was 5 hours 45 minutes, median blood loss 500 mL, and median length of hospital stay 9 days. Complications included one patient with chylous ascites and one with a prolonged air leak, both of which resolved with conservative management. Eighteen patients had similar pathologic findings in all sites: 13 with necrosis only and five with teratoma only. Six patients had discordant pathology in the abdomen and chest, including one with viable tumor in the chest only and two with viable tumor in the abdomen only. The overall actuarial 5-year survival rate for all patients was 79%.
CONCLUSION: Simultaneous resection of neck, chest, and abdominal residual masses after chemotherapy for germ cell tumors is both a feasible and safe alternative to staged excision in selected patients who require surgical intervention at multiple sites and fulfills the objective of rendering patients disease-free in a single operative procedure.

Entities:  

Mesh:

Year:  1996        PMID: 8656244     DOI: 10.1200/JCO.1996.14.6.1765

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  9 in total

Review 1.  Advances in the treatment of testicular cancer.

Authors:  Hans-Georg Kopp; Markus Kuczyk; Johannes Classen; Arnulf Stenzl; Lothar Kanz; Frank Mayer; Michael Bamberg; Jörg Thomas Hartmann
Journal:  Drugs       Date:  2006       Impact factor: 9.546

2.  Canadian consensus guidelines for the management of testicular germ cell cancer.

Authors:  Lori Wood; Christian Kollmannsberger; Michael Jewett; Peter Chung; Sebastian Hotte; Martin O'Malley; Joan Sweet; Lynn Anson-Cartwright; Eric Winquist; Scott North; Scott Tyldesley; Jeremy Sturgeon; Mary Gospodarowicz; Roanne Segal; Tina Cheng; Peter Venner; Malcolm Moore; Peter Albers; Robert Huddart; Craig Nichols; Padraig Warde
Journal:  Can Urol Assoc J       Date:  2010-04       Impact factor: 1.862

3.  Role of postchemotherapy surgery in the management of patients with liver metastases from germ cell tumors.

Authors:  Jörg Thomas Hartmann; Oliver Rick; Karin Oechsle; Markus Kuczyk; Thomas Gauler; Patrick Schöffski; Jan Schleicher; Frank Mayer; Reinhard Teichmann; Lothar Kanz; Carsten Bokemeyer
Journal:  Ann Surg       Date:  2005-08       Impact factor: 12.969

4.  The efficacy of radio-frequency ablation for metastatic lung or liver tumors of male germ cell tumors as an alternative minimally invasive therapy after salvage chemotherapy.

Authors:  Yoshio Naya; Terukazu Nakamura; Masakatsu Oishi; Takashi Ueda; Hiroyuki Nakanishi; Yasuyuki Naitoh; Fumiya Hongo; Kazumi Kamoi; Koji Okihara; Osamu Tanaka; Takuji Yamagami; Kei Yamada; Tsuneharu Miki
Journal:  Int J Clin Oncol       Date:  2015-04-30       Impact factor: 3.402

Review 5.  Surgical salvage in patients with advanced testicular cancer: indications, risks and outcomes.

Authors:  Ryan W Speir; Clint Cary; Timothy A Masterson
Journal:  Transl Androl Urol       Date:  2020-01

Review 6.  Postchemotherapy surgery for germ cell tumors--what have we learned in 35 years?

Authors:  Stephen B Riggs; Earl F Burgess; Kris E Gaston; Caroline A Merwarth; Derek Raghavan
Journal:  Oncologist       Date:  2014-04-09

Review 7.  Diagnosis and treatment of patients with testicular germ cell cancer.

Authors:  J T Hartmann; L Kanz; C Bokemeyer
Journal:  Drugs       Date:  1999-08       Impact factor: 9.546

8.  Canadian Urological Association consensus guideline: Management of testicular germ cell cancer.

Authors:  Robert J Hamilton; Christina Canil; Noa Shani Shrem; Kopika Kuhathaas; Maria Di Jiang; Peter Chung; Scott North; Piotr Czaykowski; Sebastien Hotte; Eric Winquist; Christian Kollmannsberger; Armen Aprikian; Denis Soulières; Scott Tyldesley; Alan I So; Nicholas Power; Ricardo A Rendon; Martin O'Malley; Lori Wood; Michael A S Jewett
Journal:  Can Urol Assoc J       Date:  2022-06       Impact factor: 2.052

Review 9.  Management of post-chemotherapy extra-retroperitoneal residual masses.

Authors:  Brett S Carver; Joel Sheinfeld
Journal:  World J Urol       Date:  2009-04-17       Impact factor: 4.226

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.